These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6223415)

  • 21. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.
    Burlingham WJ; Grailer AP; Fechner JH; Kusaka S; Trucco M; Kocova M; Belzer FO; Sollinger HW
    Transplantation; 1995 Apr; 59(8):1147-55. PubMed ID: 7732562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses.
    Mathew JM; Blomberg B; Fuller L; Burke GW; Ciancio G; Kenyon N; Ricordi C; Tzakis AG; Esquenazi V; Miller J
    J Immunol Methods; 2003 Jan; 272(1-2):67-80. PubMed ID: 12505713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human cytotoxic lymphocytes directed against cells infected with typhus group rickettsiae: evidence for lymphokine activation of effectors.
    Carl M; Dasch GA
    J Immunol; 1986 Apr; 136(7):2654-61. PubMed ID: 3081648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unresponsiveness of antidonor cytotoxic T cells in a long-term stable renal transplant recipient.
    Fujiwara T; Sakagami K; Saito S; Uda M; Orita K
    Acta Med Okayama; 1994 Feb; 48(1):63-5. PubMed ID: 8191919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis.
    Bishop GA; Waugh JA; Hall BM
    Transplantation; 1988 Aug; 46(2):303-10. PubMed ID: 2970135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients.
    Hadley GA; Anderson CB; Mohanakumar T
    Transplantation; 1992 Aug; 54(2):333-7. PubMed ID: 1386694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
    Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
    J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreas and kidney allograft-infiltrating cells in simultaneous pancreas-kidney transplantation.
    Boonstra JG; Deckers JG; Laterveer JC; Price V; van Es LA; Bruijn JA; Daha MR; van der Woude FJ
    Transplantation; 1997 May; 63(10):1470-5. PubMed ID: 9175812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of human cytomegalovirus-specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system.
    Charpentier B; Michelson S; Martin B
    J Immunol; 1986 Jul; 137(1):330-6. PubMed ID: 2423608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.
    Cheigh JS; Suthanthiran M; Kaplan M; Evelyn M; Riggio RR; Fotino M; Schechter N; Wolf CF; Stubenbord WT; Stenzel KH
    Transplantation; 1984 Nov; 38(5):501-6. PubMed ID: 6238460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic T cell activity after HLA-mismatch bone marrow transplantation.
    Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
    Tokai J Exp Clin Med; 1996 Feb; 21(1):19-23. PubMed ID: 9239800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of allograft rejection by donor-specific lymphocyte-mediated cytolysis: cloning of cytotoxic lymphocytes from positive patients.
    Durinović-Belló I; Pasini J; Barisić D; Thune S; Puretić Z; Gerencer M; Tomasković Z; Kastelan A
    Transplant Proc; 1987 Oct; 19(5):4283-5. PubMed ID: 3314029
    [No Abstract]   [Full Text] [Related]  

  • 40. Donor-specific decreased primary and secondary cell-mediated immune responses in patients with well functioning grafts.
    Pfeffer PF; Hirschberg H; Thorsby E
    Transplant Proc; 1981 Sep; 13(3):1604-6. PubMed ID: 6458131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.